| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.08B | — | +15.2% |
| Gross Profit | $507.0M | — | +14.2% |
| R&D Expense | $81.0M | — | +15.7% |
| SG&A Expense | $190.0M | — | +2.7% |
| Operating Income | $149.0M | — | +34.2% |
| Interest Expense | $45.0M | — | -15.1% |
| Pre-tax Income | $102.0M | — | +72.9% |
| Income Tax | $18.0M | — | +157.1% |
| Net Income | $84.0M | — | +61.5% |
| EPS (Basic) | $1.24 | — | +61.0% |
| EPS (Diluted) | $1.18 | — | +53.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $463.0M | +10.8% | +13.8% |
| Accounts Receivable | $775.0M | +19.0% | +21.3% |
| Inventory | $949.0M | +3.0% | +6.2% |
| Current Assets | $2.54B | +1.4% | +4.9% |
| Total Assets | $8.73B | -0.8% | +2.0% |
| Current Liabilities | $2.29B | +147.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $53.0M | — | -62.4% |
| Capital Expenditures | $25.0M | — | +38.9% |
| Investing Cash Flow | -$25.0M | — | -38.9% |
| Financing Cash Flow | -$137.0M | — | +23.9% |
| Free Cash Flow | $28.0M | — | -77.2% |
| +193.3% |
| Long-term Debt | $2.65B | -36.1% | -39.9% |
| Total Liabilities | $5.92B | -2.6% | -4.6% |
| Stockholders' Equity | $2.81B | +3.4% | +19.4% |